| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.23 | 2e-06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.22 | 1e-05 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.16 | 0.0003 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |